COVID-19 Research Working Group

Leading Coronavirus Research


A Third of Americans Say They Are Unlikely or Hesitant to Get COVID-19 Vaccine

January 29, 2021

News reports indicate COVID-19 vaccines are not getting out soon enough nor in adequate supplies to most regions, but there may be a larger underlying problem than shortages. A University of California, Davis, study found that more than a third of people nationwide are either unlikely or at least hesitant to get a COVID-19 vaccine when it becomes available to them.

Twelve COVID-19 treatments being tested at UC Davis School of Medicine

January 28, 2021

One year after the first patient with COVID-19 was diagnosed in the U.S., the world is still searching for safe and effective drugs to treat the coronavirus. UC Davis School of Medicine researchers have partnered with many drug developers to test potential therapies and vaccines. Currently, they are recruiting for more than 12 clinical trials to find potent COVID-19 treatments.

UC Davis Launches $3 Million Project to Improve Farmworker COVID Safety

January 27, 2021

California’s 800,000 farmworkers have been hit hard by COVID-19, the disease that has infected more than 25 million people and killed more than 420,000 in the United States. Farmworkers are especially vulnerable to the airborne virus that causes COVID-19 because they often live, work and carpool in close quarters with other people. As essential employees, farmworkers have stayed on the job during the pandemic to plant, process and harvest the nation’s food.

Rhesus Macaques Develop Promising Immune Response to SARS-CoV-2

January 22, 2021

In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine. The work was carried out at the California National Primate Research Center at the University of California, Davis, and is published Jan. 22 in the journal Nature Communications.